Zevra Therapeutics, Inc. (ZVRA)

Zevra Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	95.6	62.41	33.79	43.05	65.47	112.35
Short-Term Investments	105.02	128.61	35.71	24.69	17.38	-
Cash & Short-Term Investments	200.62	191.01	69.5	67.74	82.85	112.35
Cash Growth	220.31%	174.85%	2.60%	-18.24%	-26.26%	2566.65%
Accounts Receivable	22.1	23.26	10.51	17.38	8.3	1.53
Inventory	2.31	1.74	1.97	-	-	-
Other Current Assets	4.94	7	4.05	1.82	1.69	1.18
Total Current Assets	229.97	223.01	86.03	86.94	92.83	115.06
Net Property, Plant & Equipment	1.52	1.7	1.01	1.53	1.78	2.03
Other Intangible Assets	6.11	6.42	68.99	69.23	-	-
Goodwill	4.7	4.7	4.7	4.7	-	-
Long-Term Investments	36.15	47.88	6.01	-	20	15.42
Other Long-Term Assets	0.14	1.02	11.38	9.94	0.72	0.44
Total Assets	278.58	284.73	178.13	172.33	115.34	132.94
Accounts Payable	11.69	11.6	25.46	28.4	6.17	3.04
Accrued Expenses	20.35	13.71	-	-	-	-
Short-Term Debt	-	-	-	37.7	-	-
Current Portion of Leases	0.41	0.42	0.42	0.54	0.48	0.36
Other Current Liabilities	14.58	13.55	8.19	7.07	5.37	0.84
Total Current Liabilities	47.03	39.28	34.07	73.72	12.02	4.23
Long-Term Debt	-	61.93	59.5	5.07	12.8	-
Long-Term Leases	0.74	0.86	0.37	0.46	0.84	1.23
Other Long-Term Liabilities	25.01	28.01	44.52	31.22	14.55	0.36
Total Long-Term Liabilities	25.75	90.8	104.4	36.74	28.2	1.59
Total Liabilities	72.78	130.07	138.46	110.46	40.22	5.82
Common Stock	0.01	0.01	0.01	0	0	0
Treasury Stock	-10.98	-10.98	-10.98	-10.98	-7.54	-2.81
Additional Paid-in Capital	602.75	588.46	555.3	472.66	436.27	396.96
Accumulated Other Comprehensive Income	-1.8	-0.76	0.63	-	-	-
Retained Earnings	-384.17	-422.06	-505.29	-399.78	-353.73	-267.03
Shareholders' Equity	205.8	154.66	39.67	61.91	75.01	127.12
Total Liabilities & Equity	278.58	284.73	178.13	172.33	115.34	132.94
Total Debt	1.15	63.21	60.3	43.77	14.12	1.59
Net Cash (Debt)	199.47	127.81	9.2	23.97	68.72	110.76
Net Cash Growth	56.07%	1289.18%	-61.62%	-65.12%	-37.95%	-
Net Cash Per Share	3.45	2.23	0.20	0.68	1.99	3.72
Book Value	205.8	154.66	39.67	61.91	75.01	127.12
Book Value Per Share	3.56	2.70	0.86	1.75	2.17	4.27
Tangible Book Value	195	143.54	-34.03	-12.02	75.01	127.12
Tangible Book Value Per Share	3.37	2.51	-0.74	-0.34	2.17	4.27

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q